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Six commercially available bacterial identification products were tested with Vibrio alginolyticus (12 strains),
V. cholerae (30 strains), Photobacterium (Vibrio) damselae (10 strains), V. fluvialis (10 strains), V. furnissii (4
strains), V. hollisae (10 strains), V. metschnikovii (9 strains), V. mimicus (10 strains), V. parahaemolyticus (30
strains), and V. vulnificus (10 strains) to determine the accuracy of each system for identification. The products
included API 20E, Crystal E/NF, MicroScan Neg ID2 and Rapid Neg ID3, and Vitek GNI and ID-GNB. Each
product was tested only with those species that were listed in its database. Overall, the systems correctly
identified 63.9, 80.9, 63.1, 73.6, 73.5, and 77.7% of the isolates to species level, respectively. Error rates ranged
from 0.8% for the API 20E to 10.4% for the Rapid Neg ID3. The API 20E gave “no identification” for 13.1% of
the isolates, while the Neg ID2, GNI, ID-GNB, and Crystal were unable to identify 1.8, 2.9, 5.0, and 6.9%,
respectively. For V. cholerae, specifically, accuracy ranged from 50.0 to 96.7%, with the API 20E having the worst
performance and Crystal having the best. V. fluvialis presented the biggest challenge for the API 20E and the
GNI, with probabilities averaging 10%, while V. mimicus was a major problem with the Crystal E/NF, which
identified none of the strains correctly. With the Neg ID2, correct answers were often obtained only after a
modified inoculation of the panel with a bacterial suspension prepared with 0.85% NaCl. Additional tests
required for identification often included growth in the absence of NaCl, which is not readily available in most
clinical laboratories. The only product to correctly identify at least 90% of V. cholerae strains was the Crystal
E/NF, and only three of the six products, the API 20E and both of the Vitek cards, correctly identified more than
90% of the V. parahaemolyticus strains. Thus, extreme care must be taken in the interpretation of answers from
these six commercially available systems for the identification of Vibrio species.
There are approximately 63 species of Vibrio (www.bacterio
.cict.fr), of which 12 occur in human clinical specimens (11). Of
particular interest to clinical microbiology laboratories is
Vibrio cholerae, which has been the cause of many epidemics
and deaths and which is generally acknowledged to be of se-
rious concern to those currently involved in bioterrorism. In-
deed, when the list of critical agents for bioterrorism and civil
preparedness was released (21), V. cholerae was classified as a
biothreat level B, which is defined as an agent having a mod-
erate ease of transmission and morbidity with a low rate of
mortality (31). Thus, correct identification of this organism and
its differentiation from other species of the genus are impor-
tant.
Other species of Vibrio such as V. vulnificus, which has a
fatality rate of approximately 50% in patients with primary
septicemia, also cause significant human disease (11). Photo-
bacterium (Vibrio) damselae, V. metschnikovii, and V. cincin-
natiensis have all been isolated from patients with bacteremia
or meningitis (7, 12, 14, 15, 29). V. parahaemolyticus is also the
cause of many outbreaks (11).
Commercial bacterial identification systems are used in the
vast majority of hospital-based clinical microbiology laborato-
ries. To date, there has not been a comprehensive evaluation
of the ability of these systems to accurately identify the 12
species of Vibrio known to infect humans. The database ma-
trices of all six systems do not include all 12 of the species, but
all systems claim the capability to identify V. alginolyticus, V.
cholerae, P. damselae, V. parahaemolyticus, and V. vulnificus.
This study evaluated the ability of the six commercially avail-
able bacterial identification systems to accurately identify
members of the family Vibrionaceae.
(This paper was presented in part at the 103rd Annual Meet-
ing of the American Society for Microbiology, Washington,
D.C., 19 to 22 May 2003 [C. M. O’Hara, E. G. Sowers, C. A.
Bopp, N. A. Strockbine, and J. G. Wells, Abstr. Annu. Meet.
Am. Soc. Microbiol., abstr. C008, p. 118, 2003]).
MATERIALS AND METHODS
Identification systems and software. The six systems used in this study were
the API 20E strip (bioMérieux Inc., Durham, N.C.) with profile index version 4.0,
the Crystal E/NF panel (Becton Dickinson & Company, Sparks, Md.) with
software version 4.0, the MicroScan Neg ID type 2 and the Rapid Neg ID type
3 panels (Dade Behring Inc., MicroScan Inc., West Sacramento, Calif.) with
LabPro version 1.133, and the Vitek GNI and ID-GNB cards (bioMérieux Inc.)
with software version 7.01 on the Vitek 32 instrument and version 2.03 on the
Vitek 2 instrument. The MicroScan panels were analyzed on a MicroScan SI
instrument. All products were inoculated and read according to the directions of
the respective manufacturers.
All six cards and panels are products that have been the subject of extensive
publications in the past. Readers are referred to prior reports for more details on
the products (22–24, 30).
Culture collection. All 125 strains of biochemically typical and 10 atypical (3
strains each of V. alginolyticus and V. damselae and 4 strains of V. hollisae)
members of the family Vibrionaceae were taken from the culture collections of
* Corresponding author. Mailing address: Centers for Disease Con-
trol and Prevention, Mailstop C16, Atlanta, GA 30333. Phone: (404)
639-2316. Fax: (404) 639-3822. E-mail: cmo1@cdc.gov.
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either the Diagnostic Microbiology Section (DMS), Epidemiology and Labora-
tory Branch, Division of Healthcare Quality Promotion, or the Foodborne and
Diarrheal Diseases Laboratory Section (FDDLS), Foodborne and Diarrheal
Diseases Laboratory Branch, Division of Bacterial and Mycotic Diseases, Cen-
ters for Disease Control and Prevention (CDC). An isolate is considered atypical
if there are no more than three characteristics exhibited by that isolate that are
present less than 5% of the time (e.g., a citrate-positive isolate of a species that
is normally 95% citrate negative). The 10 atypical strains that were used in this
study exhibited only one unusual characteristic per isolate. The cultures were
maintained in either defibrinated sheep blood (DMS) or tryptic soy broth with
20% glycerol (FDDLS) at 70°C and were passaged four times on tryptic soy
agar with 5% sheep blood (TSA II; Becton Dickinson Biosciences Inc., Sparks,
Md.) before testing. For studies with the MicroScan Rapid Neg ID3 panels, the
fourth passage was on MacConkey agar. All incubations were at 35  1°C, unless
otherwise indicated. If the isolate did not grow on MacConkey agar, the inocu-
lum was taken from a fourth passage on a sheep blood agar plate. For the initial
testing of any given isolate, all products were inoculated from the same blood or
MacConkey agar plate.
Only the species that were included in a respective system’s database were
included in that part of the evaluation, i.e., not all isolates were tested in all
systems. However, the number of isolates of a given species remained constant
across the systems.
If an initial identification was in error, two additional tests were done simul-
taneously. The best two of three answers were used for the categorization of that
isolate.
Media, biochemical tests, and serology. Biochemical tests for enteric identi-
fication were performed with conventional media and methods described by
Edwards and Ewing (9), with some modifications by Hickman and Farmer (16)
and Farmer et al. (10). Commercial media were used whenever possible.
If an identification required serology for confirmation of V. cholerae or V.
parahaemolyticus, it was performed as described by Shimada et al. (28) with V.
parahaemolyticus antiserum obtained from Denka-Seiken Co., Ltd. (Tokyo, Ja-
pan) and V. cholerae antiserum produced in-house.
Additional tests. If the probability level of an identification was below that
established as the minimum acceptable level for a given product, additional tests
were performed to achieve an identification. The additional tests were different
for each product and often were not tests that are in common use in clinical
microbiology laboratories. Those that were required in this study are listed
below.
API 20E required tests for fermentation of glucose, cellobiose, trehalose, and
xylose; growth on MacConkey agar; production of gas from glucose; esculin;
motility; methyl red; growth in 4% sodium chloride (NaCl); and resistance to the
vibriostatic agent O129.
The Crystal E/NF required tests only for the reduction of nitrate, Voges-
Proskauer, production of H2S, and ornithine decarboxylation.
The MicroScan conventional overnight product required tests for oxidase,
Christensen’s urea, fermentation of trehalose, production of gas from glucose,
liquefaction of gelatin, methyl red, motility, DNase, and growth of the organism
in 0, 6, or 8% NaCl.
The MicroScan rapid panel required tests for the fermentation of sucrose,
adonitol, rhamnose, and cellobiose; oxidase; Voges-Proskauer; arginine; flagella
stain; Vibrio nitrate reduction (supplemented with 1% NaCl); and the ability to
grow in the presence of 0, 8, or 10% NaCl.
The Vitek GNI card required only the test for the ability to grow in the
presence of 6.5% NaCl or serologic confirmation of an identification.
The Vitek ID-GNB additional tests included oxidase, motility, indole, pigmen-
tation, and hemolysis on sheep blood agar.
Definitions. “Correct” indicates that the product gave the correct genus and
species at the end of the designated incubation time with no additional tests
required.
“No ID” indicates that the product gave an identification of “no ID,” “unac-
ceptable ID,” or “unidentified” at the end of the designated incubation time.
“Correct—low probability” means that the correct answer was given but at a
probability level below that established as the minimum acceptable level for each
respective product. This level differs for each product. For both of the Vitek
products, it is 90%; for both of the MicroScan panels, it is 85%. The answer from
the Crystal E/NF must be 0.9000 or additional tests are required for an answer
to be generated. An API 20E answer must be categorized as “excellent,” “very
good,” “acceptable,” or “good” or additional tests are required for the comple-
tion of an identification.
“Inconclusive” means that the product gave an incorrect genus and species but
at a probability level below that established as the minimum acceptable level for
that product. It could also mean that the product gave three different answers on
each of the three tests for a given isolate.
“Error” means that the product gave an incorrect genus and species at a
probability level above that established as the minimum acceptable level for each
respective product.
RESULTS AND DISCUSSION
Table 1 shows the composite results from testing of all six
products. These percentages represent the numbers of answers
that were correct at the end of the initial incubation time for a
given product without the use of additional tests.
API 20E. This manual product contains 20 conventional
substrates that are inoculated with a 0.85% saline suspension
of organism and that require overnight incubation with the
addition of reagents before reading. Table 2 shows the test
results for 122 strains from eight species that are included in
the database of this product. The API performed best on the
identification of V. alginolyticus, V. parahaemolyticus, and P.
damselae, with accuracies of 91.6% or greater. At 24 h, it was
able to identify only 50.0% of V. cholerae strains and none of
the V. fluvialis or V. hollisae strains that were tested. Of the 15
V. cholerae strains that it could not identify, it rendered “no
ID” on nine and erred only on one strain, calling it Aeromonas
TABLE 1. Accuracy of identification of isolates from 10 Vibrio species by six commercial systemsa
Species
Accuracy (%) with:
API 20E Crystal E/NF MicroScanNeg ID2
MicroScan
Rapid Neg ID3 Vitek GNI Vitek ID-GNB
V. alginolyticus 91.6 66.6 16.6 100 91.6 50.0
V. cholerae 50.0 96.7 86.6 73.3 66.6 73.3
P. damselae 100 100 100 100 80.0 100
V. fluvialis 0 80.0 90.0 NAb 20.0 90.0
V. furnissii NA NA NA 100 NA NA
V. hollisae 0 90.0 10.0 100 NA NA
V. metschnikovii NA 88.8 NA 66.6 NA 33.3
V. mimicus 70.0 0 90.0 100 NA 100
V. parahaemolyticus 96.6 83.3 83.3 40.0 96.6 90.0
V. vulnificus 60.0 90.0 50.0 60.0 50.0 70.0
Totals 63.9 80.9 63.1 73.6 73.5 77.7
a Boldface indicates accuracy 90%.
b NA, not included in the database.
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hydrophila. Nine strains of V. hollisae required additional tests
for completion of the identification. One of these tests was
growth on MacConkey agar. The matrix of the database was
constructed with a 99% positive rate for this test. Because none
of our strains of V. hollisae grew on MacConkey agar, all of the
answers were correct, but categorized as “good likelihood, low
selectivity.”
Crystal E/NF. This manual product contains 30 conventional
and enzymatic substrates plus two off-line tests (oxidase and
spot indole) and also requires 18 h of incubation but does not
need to have reagents added before it is read. Once inoculated,
it is a completely closed system, ensuring greater safety for the
user. Table 3 shows the results of testing 131 strains from nine
different species. Accuracy of identifications was 90% or
greater with four species: V. cholerae, P. damselae, V. hollisae,
and V. vulnificus. Of the V. parahaemolyticus strains, 83.3%
were correctly identified. There is no single reason that none of
the V. mimicus strains were correctly identified.
MicroScan Neg ID type 2. This panel contains 28 conven-
tional biochemical substrates and six antimicrobial agents and
requires overnight incubation with the addition of reagents
before it is read. When the panel is inoculated according to the
manufacturer’s directions, the inoculum is made up in water
with Pluronic, a proprietary substance that is believed to serve
as a surfactant. As a result, many of the salt-requiring vibrios
give an identification of “Vibrio sp. SF” (slow fermenter) at an
accuracy averaging 98%. All of these identifications also con-
tained the footnote “T,” explaining that the halophilic vibrios
(V. alginolyticus, P. damselae, V. fluvialis, V. hollisae, V. parah-
aemolyticus, and V. vulnificus) require the addition of salt to
biochemical tests for species identification. If a halophilic
Vibrio is suspected, the isolate should be retested by emulsify-
ing several colonies into 3 ml of sterile 0.85% saline, with a
final turbidity equivalent to a 0.5 barium sulfate turbidity stan-
dard. The panel should then be rehydrated with 25 ml of
uninoculated water with Pluronic and 50 l of the saline sus-
pension and processed in the normal manner. For this reason,
the results of testing 122 strains of eight species have been
evaluated both without salt and then with the recommended
additional salt (Table 4). The testing of V. alginolyticus was
more accurate before the addition of salt. Once salt was added,
6 of the 12 answers were correct, but at probabilities ranging
from 84.2 to 4.9%. The accuracy for V. cholerae increased from
63.3 to 86.6% with the addition of salt to the panels, and that
for P. damselae increased from 70.0 to 100%. Accuracy for
both V. fluvialis and V. mimicus increased from 0 to 90.0%,
while accuracy for V. parahaemolyticus decreased from 83.3 to
42.1%. On the panels containing no salt, both V. alginolyticus
and V. parahaemolyticus gave the “Vibrio sp. SF” identification
at a high probability, which would lead the laboratorian to
suspect a possible vibrio. The addition of salt to the panel
made no difference in the identification of V. hollisae. Without
salt, the 10 isolates gave an identification of “Vibrio sp. SF” at
a probability of 23.8%. With salt added to the inoculum, 7 of
10 isolates were identified as V. hollisae, but only one proba-
bility exceeded 90.0%. One was called a “very rare biotype.”
Overall, the accuracy of the panels was 51.6% without salt and
63.1%, a modest increase, with salt.
In an informal survey of seven clinical microbiology labora-
tories in both medium and large hospitals and one microbiol-
ogy reference laboratory, five of the hospital-based laborato-
ries and the reference laboratory would repeat the panel using
the saline inoculum; two laboratories would send it on to their
respective state laboratories with no further work-up.
MicroScan Rapid Neg ID type 3. This panel contains a
combination of 35 conventional and enzymatic substrates that
are read at 2 h 20 min after the automatic addition of the rapid
indole reagent by the WalkAway. There are nine Vibrio species
in this database, and 125 strains were tested (Table 5). The
overall accuracy was 73.6%, with all V. alginolyticus, P. dam-
selae, V. furnissii, V. hollisae, and V. mimicus strains identified
correctly. V. parahaemolyticus was the biggest problem for this
system, with only 40.0% correctly identified at the end of the
initial incubation period. Of the remaining 18 strains, 14 were
identified as V. parahaemolyticus, but at a very low probability.
The four strains of V. cholerae that were incorrectly identi-
fied were called V. mimicus at 90% probability. Two of the
three misidentified V. vulnificus strains were called V. metschni-
kovii.
Vitek GNI. This card contains 28 conventional biochemi-
cals and requires at least 6 h of incubation time. No additional
reagents are needed in this totally sealed system. Six species of
Vibrio are included in the database, and 102 strains were tested
with a Vitek 32 (Table 6). Overall accuracy was 73.5%, with
only V. alginolyticus and V. parahaemolyticus having greater
TABLE 2. Results of testing eight species of Vibrio in the
API 20E strip (read at 18 to 24 h)
Reference ID n
No. (%) of strains with result of:
Correct
Correct—
low
probability
Incon-
clusive No ID
a Error
V. alginolyticus 12 11 1
V. cholerae 30 15 5 9 1
P. damselae 10 10
V. fluvialis 10 9 1
V. hollisae 10 9 1
V. mimicus 10 7 2 1
V. parahaemolyticus 30 29 1
V. vulnificus 10 6 1 1 2
Totals 122 78 (63.9) 26 (21.3) 1 (0.8) 16 (13.1) 1 (0.8)
a No ID, no identification.
TABLE 3. Results of testing nine species of Vibrio in the
BD Crystal E/NF panel (read at 18 h)
Reference ID n
No. (%) of strains with result of:
Correct
Correct—
low
probability
Incon-
clusive
No
IDa Error
V. alginolyticus 12 8 3 1
V. cholerae 30 29 1
P. damselae 10 10
V. fluvialis 10 8 1 1
V. hollisae 10 9 1
V. metschnikovii 9 8 1
V. mimicus 10 0 1 2 4 3
V. parahaemolyticus 30 25 3 2
V. vulnificus 10 9 1
Totals 131 106 (80.9) 9 (6.9) 2 (1.5) 9 (6.9) 5 (3.8)
a No ID, no identification.
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than 90% accuracy. Seven of the 10 answers from testing V.
fluvialis were V. fluvialis, but at probability levels below 90%,
which is the minimum acceptable threshold for this product.
Four of the five V. cholerae identifications that were in error
were V. alginolyticus at probability levels 92%. The fifth error
was a V. cholerae strain identified as V. parahaemolyticus at
92% probability.
Vitek ID-GNB. This card is the newest identification product
on the market and is used with the Vitek 2 instrument. Table
7 shows the results of testing 121 strains from nine species.
Strains of P. damselae and V. mimicus were all identified cor-
rectly, and the identifications of V. fluvialis and V. parahaemo-
lyticus were 90% accurate. Four strains of V. cholerae were
identified as V. cholerae, but at a “low discrimination” level,
and would require supplemental testing.
Very few reports expressly concerning the ability of com-
mercial systems to identify members of the genus Vibrio have
appeared, although many evaluations have incorporated small
numbers of these organisms within a larger study. Overman et
al. (25) tested 13 strains from five species of Vibrio in the API
20E with an accuracy rate of 100%.
There have been at least eight published case reports in
which V. metschnikovii was the causative organism of infection.
Of these, only once (8) was there an attempt to identify the
isolates with a commercial system, in this case the API 20E.
The report suggested that the results were not reproducible
and resulted in some incorrect identifications.
Three biogroups of V. vulnificus are recognized in the liter-
ature. Biogroup 1 is positive in tests for indole, ornithine de-
carboxylase, and fermentation of D-mannitol and negative for
the fermentation of D-sorbitol. This biogroup is generally con-
sidered to be an opportunistic pathogen for humans after the
ingestion of raw shellfish or contamination of a wound after
exposure to seawater or handling of shellfish (3). Biogroup 2 is
pathogenic for eels, the natural host for this biotype, but arti-
cles citing it as the causative agent in human infections as well
have now appeared (3). It is negative in tests for indole, orni-
thine, and D-mannitol but positive for the fermentation of
D-sorbitol. Biogroup 3 has been reported in the literature as
having been isolated from wound infections and bacteremia
(5). It is positive in tests for ornithine and indole but negative
for D-mannitol and D-sorbitol fermentations. After the selec-
tion and testing of V. vulnificus isolates were completed, we
realized that we had picked three isolates of biogroup 1 and
seven isolates of biogroup 2. Because the CDC generally re-
ceives only those isolates that cause problems in identification,
it is not unusual that our collection would include a large
TABLE 4. Results of testing eight species of Vibrio in the MicroScan Neg ID2 panel (read at 16 to 20 h)
Reference ID n
No. (%) of strains with result of:
Correct in:
Correct—low
probability Inconclusive No ID
a ErrorH2O with
Pluronic 0.85% NaCl
V. alginolyticus 12 12b 2 6 2 2
V. cholerae 30 19 26 2 2
P. damselae 10 7b 10
V. fluvialis 10 0 9 1
V. hollisae 10 0 1 7 1 1
V. mimicus 10 0 9 1
V. parahaemolyticus 30 25b 8/19c 9 1 1
V. vulnificus 10 0 5 4 1
Totals 122 63 (51.6) 70 (63.1) 30 (27.0) 5 (4.5) 2 (1.8) 4 (3.6)
a No ID, no identification.
b Panel identifications correct to genus.
c Only 19 panels repeated with salt.
TABLE 5. Results of testing nine species of Vibrio in the
MicroScan Rapid Neg ID3 panel (read at 2 h 20 min)
Reference ID n
No. (%) of strains with result of:
Correct
Correct—
low
probability
Incon-
clusive
No
IDa Error
V. alginolyticus 12 12
V. cholerae 30 22 4 4
P. damselae 10 10
V. furnissii 4 4b
V. hollisae 10 10
V. metschnikovii 9 6 1 2
V. mimicus 10 10
V. parahaemolyticus 30 12 14 4
V. vulnificus 10 6 1 3
Totals 125 92 (73.6) 20 (16.0) 13 (10.4)
a No ID, no identification.
b Identification was V. fluvialis or V. furnissii with no additional tests given to
separate the two species.
TABLE 6. Results of testing six species of Vibrio in the
Vitek GNI card (read at 2 to 8 h)
Reference ID n
No. (%) of strains with result of:
Correct
Correct—
low
probability
Incon-
clusive
No
IDa Error
V. alginolyticus 12 11 1
V. cholerae 30 20 5 5
P. damselae 10 8 1 1
V. fluvialis 10 2 7 1
V. parahaemolyticus 30 29 1
V. vulnificus 10 5 1 2 1 1
Totals 102 75 (73.5) 10 (9.8) 8 (7.8) 3 (2.9) 6 (5.9)
a No ID, no identification.
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number of suspect biogroup 2 isolates. However, what is un-
usual is that the API 20E matrix has the indole reaction con-
figured at 99% positive. All of our biogroup 2 isolates were
positive for indole on the API 20E even though they were
negative in our conventional Kovacs indole test. Four of these
seven were correctly identified. No biogroup 3 strains were
included in this study. However, Colodner et al. reported re-
sults obtained from testing 51 documented biogroup 3 strains
in the ID-GNB card, which correctly identified 90.2% of the
strains (R. Colodner, L. Lerner, J. Kopelowitz, I. Meir, Z.
Lazarovich, Y. Keness, and R. Raz, Abstr. 12th Eur. Congr.
Clin. Microbiol. Infect. Dis., abstr. P637, 2002).
There are numerous case reports of V. vulnificus in the
literature in which a commercial system was used for the initial
identification of the organism. Bisharat and Raz (6) reported
that only 12 of 25 V. vulnificus isolates from persons who had
contact with fish were correctly identified with the API 20E. In
1999, Bisharat et al. further reported that 19 isolates of V.
vulnificus from soft-tissue infections were identified as other
genera by the API 20E (5). The authors indicated that the
isolates were also tested in conventional MicroScan panels but
did not report the identifications.
In 1993, Biosca et al. (4) tested 106 isolates in the API 20E
system; however, they modified the manufacturer’s directions
so that the inoculum was made up in 0.85% NaCl and incu-
bated at 25°C. Even with these alterations in the protocol, only
13 of 17 biotype 1 strains were identified correctly, with an
accuracy of 76.5% with no additional tests. Of the 89 biotype 2
strains, none were identified correctly without additional tests.
The investigators suggested that this finding was consistent
with the database that was constructed with clinical strains. All
of their biotype 2 strains were from diseased eels, the natural
host for this biotype.
Abbott and Janda (1) reported on two cases of gastroenter-
itis associated with V. hollisae. In the first case, the API 20E
misidentified the organism, which also failed to grow in a
MicroScan conventional panel. In the second case, the API
accurately identified the bacterium. As was discussed earlier,
their isolates also failed to grow on MacConkey agar. Reina et
al. (26) reported a case of gastroenteritis caused by V. algino-
lyticus, which was correctly identified by API 20E. Finally,
Komarnicka et al. reported the first catheter site infection in a
dialysis patient caused by V. cholerae non-O1, in which the
organism was correctly identified by the API 20E (J. Komar-
nicka, A. Samet, E. Dziemaszkiewicz, and L. Maumiuk, Abstr.
11th Eur. Congr. Clin. Microbiol. Infect. Dis., abstr. P1065,
2001).
In evaluations of the Vitek 2, Funke et al. (13) tested seven
isolates of Vibrio spp. Two isolates each of V. cholerae and V.
parahaemolyticus were correctly identified, while only one of
three strains of V. alginolyticus was correctly identified. Jossart
and Courcol (18), however, had one strain each of these same
three organisms correctly identified in their study on the Vitek
2, and Ling et al. (20) reported that the result of one strain of
V. vulnificus was deemed “unidentified.”
In an evaluation of the Crystal E/NF by Holmes et al. (17),
five strains each of V. cholerae and V. parahaemolyticus were
tested. Four strains each were correctly identified, and one
strain each gave “no identification.” Robinson (27) had one
strain of V. parahaemolyticus correctly identified.
Another potential problem that must be taken into consid-
eration involves the identification of aeromonads as vibrios.
Abbott et al. (2) addressed this problem and reported on
isolates of Aeromonas schubertii and Aeromonas veronii that
were identified as P. damselae (Vitek GNI) and V. cholerae
(API 20E), respectively.
While it is a recognized fact that cholera is a potentially
devastating worldwide disease, most of the reports in the lit-
erature do not address the identification of the organism. In
many cases, selective medium is used for the initial isolation
and, once the organism is isolated, identification is confirmed
serologically. In a review of V. cholerae, Kaper et al. (19) state
that commercially available enteric identification systems are
suitable for identifying V. cholerae. Based on the study re-
ported here, we cannot agree with this statement. None of the
systems tested in our study achieved an overall accuracy of
90% for the identification of Vibrio species. Only the Becton
Dickinson Crystal E/NF achieved an accuracy level of 80%.
The only product to correctly identify at least 90% of V. chol-
erae strains was the Crystal E/NF, and only three of the six
products, the API 20E and both of the Vitek cards, correctly
identified more than 90% of the V. parahaemolyticus strains.
This study has shown that only 20 of 48 of the organism-
product combinations will yield an accurate identification. The
overall accuracy of all systems with all species that are included
in their databases is 72.1%, even though in an additional 15.2%
of the cases a correct identification would have been given, but
at a low probability requiring additional confirmatory testing.
V. cholerae would have been identified accurately in only
74.4% of the tests. In conclusion, caution must be taken in the
interpretation of answers from these six commercially available
systems for the identification of Vibrio species, with additional
confirmatory testing being required in many cases.
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